| Model 1 (Block 1) | Model 2 (Block 1–2) | Model 3 (Block 1–3) | Model 4 (Block 1–4) | ||||
---|---|---|---|---|---|---|---|---|
R2 | β | R2 | β | R2 | β | R2 | β | |
Block 1 | ||||||||
 Illness perception | 0.511 |  | 0.536 |  | 0.565 |  | .0.565 |  |
  Identity |  | −0.07 |  | −0.08 |  | −0.05 |  | −0.05 |
  Consequences |  | − 0.37** |  | −0.39** |  | − 0.34** |  | −0.34** |
  Treatment control |  | 0.04 |  | 0.06 |  | 0.04 |  | 0.04 |
  Personal control |  | 0.14 |  | 0.08 |  | 0.03 |  | 0.03 |
  Illness coherence |  | 0.01 |  | −0.04 |  | −0.04 |  | −0.05 |
  Timeline (cyclical) |  | −0.39** |  | −0.36** |  | −0.30** |  | −0.30** |
  Emotional representation |  | −0.05 |  | −0.02 |  | − 0.01 |  | - 0.00 |
Block 2 | ||||||||
 Demographic characteristics | ||||||||
  Age |  |  |  | −0.16 |  | − 0.16 |  | − 0.16 |
  Marital status |  |  |  | −0.06 |  | −0.08 |  | − 0.08 |
  Educational level |  |  |  | −0.04 |  | − 0.07 |  | −0.07 |
Block 3 | ||||||||
 Clinical characteristics | ||||||||
  Additional medication |  |  |  |  |  | 0.03 |  | 0.03 |
  Co-morbidity |  |  |  |  |  | −0.08 |  | −0.08 |
  Disease activity |  |  |  |  |  | −0.03 |  | −0.03 |
  Pain |  |  |  |  |  | 0.01 |  | 0.01 |
  Functional disability |  |  |  |  |  | −0.18 |  | −0.18 |
  Fatigue |  |  |  |  |  | −0.02 |  | −0.02 |
Block 4 | ||||||||
 Social support | ||||||||
  Detrimental interaction |  |  |  |  |  |  |  | 0.08 |
R2 change | Â | Â | 0.53 | Â | Â | 0.56 | Â | 0.63 |